Department of circulation and medical imaging, NTNU
Trondheim, Sør-Trøndelag, 7006, Norway
NCT Number: NCT01550081
Aerobic interval training is shown to be superior in increasing oxygen uptake in both healthy and patients with coronary artery disease (CAD), compared to moderate continuous training. However, in cardiac rehabilitation exercise groups, exercise intensity is usually controlled with perceived exertion (Borg scale). The investigators will investigate degree of agreement between target heart rate and perceived exertion during interval training in cardiac rehabilitation.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Trondheim, Sør-Trøndelag, 7006, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise intensity controlled by Borg scale
Exercise intensity controlled by heart rate monitors
Time frame: up to 1 hour
Exercise intensity during one-hour exercise session monitored by Borg, subsequently one-hour exercise session monitored by heart rate monitor
Norwegian University of Science and Technology
Other
Exercise Intensity and Target Heart Rate During Aerobic Interval Training in Cardiac Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details